PETALIFE-40
MRP: 55
Packaging: 40 MG
Pack Type: injection
Composition:
Pantoprazole 40mg
Indication:
Hyperacidity, Peptic Ulcers, GERO/Reflux esophagitis, Drug induced gastritis
Description:
Pantoprazole 40 mg Injection is a proton pump inhibitor (PPI) that suppresses gastric acid secretion by inhibiting the H⁺/K⁺ ATPase enzyme in the stomach lining.
This injectable form is ideal for patients who cannot take oral medications and is widely used in hospitals for:
Peptic ulcers and duodenal ulcers
Gastroesophageal reflux disease (GERD)
Erosive esophagitis
Zollinger-Ellison syndrome (gastric acid hypersecretion)
Prevention of stress ulcers in critically ill patients
Pantoprazole 40 mg injection is usually administered via slow IV injection or IV infusion.
Tags:
- Rapid and effective gastric acid suppression
- Ideal for patients who cannot take oral PPI therapy
- Prevents stress ulcers in ICU or surgical patients
- Aids in faster healing of erosive esophagitis
- Convenient once-daily dosing
Usage Information
Dosage
Route: Intravenous (IV) Dose: 40 mg once daily, administered as a slow IV push (2–15 mins) or IV infusion (15 mins) Dilution: Reconstitute with 10 mL of 0.9% sodium chloride Administration: Must be administered by trained healthcare professionals
Side Effects
Headache Diarrhea or constipation Injection site pain or phlebitis Flatulence Long-term use risks: Vitamin B12 deficiency, hypomagnesemia, bone fractures
Contraindications
Known hypersensitivity to Pantoprazole or other PPIs Concomitant use with drugs requiring gastric pH (e.g., ketoconazole) Caution in hepatic impairment and osteoporosis patients Not recommended for pediatric IV use unless directed by a physician
Availability
Pantoprazole 40 mg injection Injectable PPI for acid control Pantoprazole IV for gastric ulcers Acid suppression injection Pantoprazole hospital use Proton pump inhibitor injection